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Abstract
Extensive studies during the past four decades have identified important roles for lysine
acetylation in the regulation of nuclear transcription. Recent proteomic analyses on protein
acetylation uncovered a large number of acetylated proteins in the cytoplasm and mitochondria,
including most enzymes involved in intermediate metabolism. Acetylation regulates metabolic
enzymes by multiple mechanisms, including via enzymatic activation or inhibition, and by
influencing protein stability. Conversely, non-nuclear NAD+-dependent sirtuin deacetylases can
regulate cellular and organismal metabolism, possibly through direct deacetylation of metabolic
enzymes. Furthermore, acetylation of metabolic enzymes is highly conserved from prokaryotes to
eukaryotes. Given the frequent occurrence of metabolic dysregulation in diabetes, obesity, and
cancer, enzymes modulating acetylation could provide attractive targets for therapeutic
intervention for these diseases.
Acetylation in nuclear and cytoplasmic regulation
Protein lysine acetylation was first reported almost 50 years ago [1-3]. Following the initial
discovery of histone acetylation, extensive studies over the last four decades not only have
identified the enzymes that catalyze reversible acetylation, the protein lysine
acetyltransferases (KATs, formerly termed histone acetyltransferases, HATs) and
deacetylases (commonly known as histone deacetylases, or HDACs), but also many non-
histone substrates. Nearly all well characterized acetylation substrates localize in the
nucleus, including transcription factors and co-regulators [4,5]. Furthermore, transcription
activators and repressors can recruit KATs or HDACs, respectively, to regulate
transcription. Collectively, these studies have firmly established the critical functions of
acetylation in regulating chromatin structure and gene expression [6-8]. Although
cytoplasmic localization of HDACs and KATs has been known for some time, the only
well-established cytoplasmic function for acetylation is in regulating microtubule stability
by α-tubulin acetylation at lysine 40 [9]. Our understanding of the scope of protein
acetylation has now changed dramatically following a series of acetylation proteomic studies
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[10-15]: more than 2,000 acetylated proteins have been identified (Box 1), and most are
localized in the cytoplasm. Supporting these proteomic studies, genome-wide genetic
interaction analyses in budding yeast have linked both KATs and HDACs to many non-
nuclear proteins [16,17]. These studies have substantially expanded the spectrum of
acetylation regulation to most, if not all, major cellular processes. Several excellent reviews
have been written on the genetic and cellular function of both protein acetyltransferases and
deacetylases in metabolism [18-20]. In this review, we will discuss acetylation-mediated
regulation of a specific cellular process, intermediary metabolism, with a focus on how
acetylation regulates metabolic enzymes.
Box 1. More than 2,000 proteins are acetylated in mammalian cells
Owing to the technical difficulty of detection, an overwhelming proportion of the
acetylation studies has been focused on histones and nuclear proteins [4,5]. Unlike
phosphorylation, which can be readily detected by 32P-phosphate labeling, the low
specific activity of either 3H or 14C of acetyl group makes it difficult to analyze global
cellular protein acetylation and to detect low abundant acetylated proteins. Furthermore,
acetylation of N-terminal residues, which is a conserved and widespread modification of
most nascent proteins in eukaryotes and catalyzed by a different family of enzymes, N-α-
acetyltransferases (NATs) with narrow specificity [21], complicates such an approach
because labeling with radioactive acetyl group cannot distinguish whether the
modification is on the α-amino group of N-terminal residue or on the ε-amino group of
lysine side chains of a protein. Although the development of a specific acetyl lysine
antibody should have made it possible to globally profile lysine acetylation, its low
affinity due to relatively smaller and uncharged acetyl group has made it challenging to
efficiently precipitate acetylated proteins. Moreover, acetylated lysine residues can be
buried, therefore masking the epitope from the antibody.
Recently, an important improvement in the proteomic identification of acetylated
proteins was achieved [10]. This method utilizes the protease digestion of total cellular
extracts prior to affinity precipitation using the pan acetyllysine antibody. This digestion
probably exposes a greater number of acetylated lysines and has helped significantly to
enrich the acetylated peptides. Because the acetylated lysine residue is resistant to trypsin
digestion, this method also provides an independent confirmation of mass spectrometry
(MS) identification of acetylated peptides. Using this improved purification scheme,
combined with increased sensitivity of MS, Kim et al identified 388 lysine acetylation
sites corresponding to 195 distinct proteins from mouse liver tissues and HeLa cells [10].
Notably, 277 acetylated peptides are derived from 133 proteins that are located in the
mitochondrion, including many intermediary metabolic enzymes. The identification of
multiple acetylated metabolic enzymes offered the first peek into the extent of
acetylation-mediated regulation of metabolism, gratifyingly meeting the expectation from
early studies of mitochondrial localized SIRTs that have long suggested the functions of
acetylation in metabolic regulation.
Two subsequent acetylation proteomic studies using similar approaches significantly
expanded the acetylome of mammalian cells [11,15]. Taking advantage of continuous
improvement of MS and adding further steps such as subcellular fractionation to enrich
acetylated peptides, these two studies identified an astonishing 1,750 acetylated proteins
from a human acute myeloid leukemia cell line [11] and 978 acetylated proteins from
human liver tissue [15]. Interestingly, the acetylated proteins identified from human liver
tissue overlap more with those identified from mouse liver than to those identified in
human lymphocytes, suggesting distinct patterns of acetylation in different tissues that
are evolutionarily conserved. Together, these three acetylation studies identified nearly
2,200 acetylated proteins in mammalian cells, making the regulatory scope of acetylation
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comparable to those by other major post-translational modifications such as
phosphorylation and ubiquitylation [22]. These acetylated proteins span a wide spectrum
of protein classes, ranging from transcription factors, to kinases, ubiquitin ligases,
ribosomal proteins and metabolic enzymes, and covering a broad ranges of cellular
activities including cell cycle control, DNA damage checkpoints, cytoskeleton
organization, endocytosis, and metabolism.
Three SIRTs are localized in mitochondria and linked to metabolic
regulation
Reversible acetylation is controlled by the opposing activities of protein acetyltransferases
(KATs) and deacetylases (HDACs and SIRTs), and both are encoded by multigene families
with mammalian cells expressing at least 30 acetyltransferases and about 18 deacetylases;
all are nuclear encoded. The 18 protein deacetylases are divided into four classes. Class I
and II, consisting of 10 family members, are referred to as “classical” HDACs; their
enzymatic activity can be inhibited by trichostatin A (TSA). HDAC11 is the only class IV
HDAC, and it is insensitive to TSA. Class III protein deacetylases, commonly referred to as
SIRTs (or sirtuins, derived from its founding member, budding yeast silent mating type
information regulation two protein), includes 7 members in mammalian cells that are
structurally unrelated to HDACs, require nicotinamide adenine dinucleotide (NAD+) as a
co-substrate and can be inhibited by nicotinamide (NAM), but not by TSA [23]. Increasing
evidence links the functions of multiple SIRTs with metabolic regulation, but much less is
known about the function of KATs and HDACs in this mode of regulation.
Of the 11 HDACs, four (HDAC1, 2, 8 and 11) are localized in the nucleus and 7 (HDAC3,
4, 5, 7, 9 and 10) are either distributed in or shuttle between the nucleus and the cytoplasm
[24]. Only one HDAC, HDAC7, has been reported to localize to the mitochondria [25]. Of
the 7 mammalian SIRTs, three (SIRT3, 4, and 5) localize in the mitochondria, one (SIRT2)
in the cytoplasm, and one (SIRT1) in both the nucleus and the cytoplasm [4,26]. The
localization of multiple HDACs and SIRTs in the cytoplasm was an early indication of a
non-nuclear function of protein acetylation. The mitochondrial localization of multiple
SIRTs also suggests a possible role in metabolic regulation as many metabolic reactions
occur in mitochondria [27,28]. Genetic studies of various SIRTs in different model
organisms, including Saccharomyces cervisiae, Caenorhabditis elegans, Drosophila
melanogaster, and mice, have implicated the SIRT genes in lifespan control, caloric
restriction and other nutrient responses that are directly linked with metabolic regulation
[19,20,29-31]. These studies provide genetic evidence to support a role for SIRTs, and by
extension for acetylation, in metabolic regulation.
Do SIRT deacetylases function in metabolic regulation? SIRTs use NAD+ as an obligatory
substrate in their deacetylation reaction. A high ratio of cellular NAD+:NADH indicates a
low energy status, raising an intriguing possibility that, like the AMP-activated protein
kinase (AMPK) that senses the AMP:ATP ratio and thus cellular energy status, one or
multiple mitochondrial or cytoplasmic SIRTs might link extracellular nutrient levels to the
acetylation of various metabolic enzymes inside the cell through sensing the intracellular
NAD+:NADH ratio. Several examples in mammalian cells are consistent with this notion,
however further studies are needed to directly support this model. Glucose deprivation
impairs differentiation of skeletal myoblasts and is associated with AMPK activation and
increased transcription of the NAD+ biosynthetic enzyme NAMPT, leading to an increased
NAD+:NADH ratio and SIRT1 activity. Sirt1+/- myoblasts are more resistant to glucose
restriction, supporting the notion that nutrient conditions could affect intracellular activity of
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a SIRT through alterations in NAD+ levels [32,33]. Three targets of SIRT1, proliferator-
activated receptor-γ coactivator 1α (PGC-1α), the forkhead box O1 (FOXO1) and O3
(FOXO3a), were identified, all functioning as transcriptional regulators in the nucleus,
leaving the question still open as to whether any cytoplasmic and mitochondrial metabolic
enzymes could be directly regulated by SIRT1 which localizes in both the cytoplasm and the
nucleus.
In fasted rats, both NAMPT and NAD+ levels increase in liver, leading to elevated SIRT3
activity and increased cell survival [34]. Fasting also increases NAD+ levels and SIRT5
activity in mouse liver, resulting in a decreased acetylation and increased activity of a SIRT5
substrate carbamoyl phosphate synthetase 1 (CPS1) [35], a urea cycle enzyme which
catalyzes the initial step of the urea cycle for ammonia detoxification (Fig. 1E). It should be
pointed out that in these studies, only NAD+ levels were measured, and a mechanistic basis
for SIRTs to sense the ratio of NAD+:NADH instead of being simply dependent on NAD+
for their activity has not been shown. In fact, an in vitro study on SIRT2 found that NADH
is an extremely ineffective inhibitor with an average IC50 of an astounding 17 mM, leading
to the suggestion that physiological NAD+:NADH ratios have little effect on the SIRT2
activity [36].
Analyses of different mitochondrial Sirt genes using mouse knock-out models have been
developed over the past few years and have provided genetic support for the function of
individual Sirt genes in the regulation of metabolic enzymes. Although developmentally
normal, mice with a singular deletion of Sirt3, Sirt4 or Sirt5 exhibit defects in the activity of
various metabolic enzymes, including defects in basal ATP levels and fatty-acid oxidation in
Sirt3 null mice [37-39], abnormally increased activity of glutamate dehydrogenase (GDH)
activity and insulin secretion in Sirt4 null mice [40], and decreased activity of CPS1 and
reduced urea cycle function in Sirt5 null mice [35].
A critical piece for the understanding of metabolic regulation by acetylation missing from
these genetic and functional studies is the substrates of the cytoplasmic and mitochondrial
protein acetyltransferases and deacetylases. This vacuity has now been filled quickly and
plentifully by the flurry of recent acetylation proteomic studies [10-12,15], which have
identified a large number of acetylated protein as metabolic enzymes. Moreover, emerging
data support a role of acetylation in regulating metabolic enzyme functions.
Most metabolic enzymes are acetylated
Of the nearly 2,200 acetylated proteins identified by acetylation proteomic studies in
mammalian cells[10-12,15], metabolic enzymes represent a significant portion of acetylated
proteins, due in large part to the use of liver tissues in two of the studies. Nearly all enzymes
involved in glycolysis, gluconeogenesis, the tricarboxylic acid (TCA) cycle, fatty acid
oxidation, the urea cycle and nitrogen metabolism, and glycogen metabolism are acetylated
(Figure 1). Moreover, enzymes involved in oxidative phosphorylation and amino acid
metabolism are abundantly acetylated.
The finding that metabolic enzymes are extensively acetylated in tissues or organs such as
liver which are engaged in active metabolism was further supported by a smaller and
targeted acetylation proteomic study in mouse liver mitochondria [12]. In this study, liver
mitochondrial extracts were prepared from mice subjected to a stepwise calorie restriction
(CR) protocol over a period of 4 months. Acetylated proteins were affinity purified using a
pan anti-acetyllysine antibody, digested with trypsin and analyzed by mass spectrometry
(MS). Of the 287 total acetylated proteins identified in this study, at least 165, including
many metabolic enzymes, are mitochondrially localized. Semi-quantitative MS analysis
identified 72 proteins whose acetylation levels increased during calorie restriction. An
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increase of acetylation in multiple metabolic enzymes during CR is supported by
immunoblotting of total liver lysates with the pan anti-acetyllysine antibody. Whether CR
increases the overall acetylation of mitochondrial proteins, through activating a protein
acetyltransferase(s), inhibiting a deacetylase(s), and/or decreasing the cellular NAD+
concentration, remains be elucidated. The fact that the acetylation levels of the vast majority
of metabolic enzymes are increased and very few, if any, are decreased is surprising and
suggests that only a limited number of acetyltransferases or deacetylases are involved in the
regulation of a large number of metabolic enzymes. Although there is little evidence, the
CR-induced acetylation could be caused by a non-enzymatic reaction due to alterations in
mitochondrial metabolites, such as acetyl-CoA. Below, we discuss the acetylation-mediated
regulation of individual metabolic pathways in greater detail.
Carbon metabolism
Salmonella enterica acetyl-CoA synthetase (AceS) was the first acetylation-regulated
metabolic enzyme to be identified. AceS catalyzes the production of acetyl-CoA from
acetate and CoA along with the hydrolysis of ATP to AMP [41]. Acetyl-CoA can enter
either the TCA cycle for energy production or the glyoxylate cycle for intermediate
biosynthesis and glucose production. The ability of acetyl-CoA to enter the glyoxylate cycle
is essential for bacteria to grow on nonfermentable carbon sources, such as acetate or
proprionate. S. enterica AceS is acetylated on lysine residue 609, a residue that is essential
for AceS catalysis and is highly conserved from prokaryotes to human[41]. Indeed, elegant
biochemical experiments showed that acetylation of lysine 609 blocks the formation of the
adenylate intermediate, but does not affect the thioester forming activity of AceS. As
expected, acetylation strongly inhibits AceS activity both in vitro and in vivo. S. enterica has
one SIRT family member, CobB. AceS purified from a cobB mutant strain is ~100 fold less
active than that purified from wild type cells. Moreover, cobB mutant cells grow poorly on
proprionate or acetate medium. Furthermore, in vitro treatment with recombinant CobB
strongly increases the activity of purified AceS. These data have convincingly established
that acetylation inhibits AceS activity.
Two independent studies showed that the mammalian AceS is similarly regulated by
acetylation on the corresponding lysine residues [42,43]. Mammalian cells have two AceS
isoforms, one expressed in the cytoplasm (AceS1) and the other in the mitochondrion
(AceS2). Both AceS proteins share strong homology with the bacterial AceS and produce
acetyl-CoA. However, the acetyl-CoA produced by AceS1 and AceS2 enters different
metabolic pathways: whereas the acetyl-CoA produced by the cytosolic AceS1 provides a
critical substrate for biosynthesis such as fatty acid synthesis, the acetyl-CoA generated by
the mitochondrial AceS2 is used for cellular energy production by entering the TCA cycle.
Biochemical experiments show that purified AceS1 can be acetylated in vitro by a bacterial
protein acetyltransferase, PAT. PAT acetylates AceS1 primarily on lysine 661, which is
equivalent to lysine 609 in the S. enterica AceS. Similar to the results observed with the
bacterial AceS, in vitro acetylation also inactivates mammalian AceS1. Acetylated AceS1
can be efficiently deacetylated by SIRT1, but not SIRT2, and deacetylation results in AceS1
activation. Similar experiments with the mitochondrial AceS2 showed that it is also
inactivated by in vitro acetylation with PAT. The mitochondrial SIRT3 has been suggested
to deacetylate and activate AceS2 [42,43]. Therefore, reversible acetylation appears to be an
ancient mechanism involved in the regulation of AceS. Glyceraldehyde 3-phosphate
dehydrogenase (GAPDH), encoded by GapA in S. enterica, catalyzes the reversible reaction
between the conversion of glyceraldehyde 3-phosphate and 1,3-bisphosphoglycerate in both
glycolysis and gluconeogenesis. Therefore, this enzyme is required for S. enterica to utilize
either glucose or acetate as a carbon source. A recent report shows that GAPDH is
acetylated, and that its acetylation is strongly increased in cobB mutant Salmonella [14].
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Interestingly, GAPDH acetylation is higher in cells grown on glucose than those grown on
acetate, indicating that GAPDH acetylation is regulated by different carbon sources. PAT
mediated GAPDH acetylation increases the glycolytic activity of GAPDH, but inhibits the
ability of GAPDH to promote the gluconeogenesis. Conversely, deacetylation by CobB
increases GAPDH gluconeogenic activity, but inhibits its glycolytic activity. These
observations suggest an exciting model wherein GAPDH acetylation might play a key role
in regulating the direction of carbon flux in response to differential nutrient availability.
Under glucose-rich conditions, high GAPDH acetylation favors glycolysis; therefore
glucose will be used as carbon source for growth. By contrast, under acetate-rich conditions,
decreased GAPDH acetylation favors the gluconeogenic direction of the pathway.
Therefore, acetate can be used to generate intermediates for biosynthesis and growth. The
precise mechanism of this intricate regulation of GAPDH acetylation is not fully
understood; however, it might stem from the transcriptional regulation of Pat and CobB
gene expression in response to different carbon sources. It is worth noting that mammalian
GAPDH is also acetylated; it would be interesting to test whether it is similarly regulated
and how cellular metabolic conditions might control this mode of regulation.
In addition to its well known function in glycolysis, human GAPDH has also been found in
and is essential for the function of the multi-component Oct-1 coactivator (OCA-S)
complex, which is essential for S phase-dependent histone H2B transcription [44]. GAPDH
binds the H2B promoter both in vivo and in vitro and more importantly, the activity of OCA-
S is modulated by the cellular NAD+:NADH ratio, suggesting that the involvement of
GAPDH in Oct-1 function might link the cellular energy status to cell cycle control. As
many as six acetylated lysine residues have now been identified in GAPDH [11,15]. More
recently, a direct regulation of GAPDH by acetylation was reported [45]; GAPDH associates
with and is acetylated by overexpressed PCAF (p300/CBP-associated factor)
acetyltransferase, leading to GAPDH nuclear translocation. It will be interesting to
determine whether acetylation also affects GAPDH activity during glycolysis, thereby
coupling glycolytic rate and energy status to cell proliferation via regulated GAPDH nuclear
translocation.
Phosphoenolpyruvate carboxykinase (PEPCK) is a rate limiting regulatory enzyme involved
in the switch between glycolysis and gluconeogenesis (Fig. 1A) [46]. It catalyzes the
irreversible step of converting oxaloacetate to phosphoenolpyruvate. PECK transcription,
and protein stability depend on the cell’s need for glucose. A protein acetylation microarray
assay in budding yeast revealed that the yeast PEPCK is acetylated and deacetylated by the
nucleosome acetyltransferase of H4 (NuA4) complex and Sir2 deacetylase, respectively
[47]. Analysis of human liver samples has identified three acetylation sites in PEPCK [15].
Moreover, PEPCK acetylation in cultured cells is regulated by nutrients in the media. High
glucose increases PEPCK acetylation whereas addition of amino acids into glucose-free
medium decreases PEPCK acetylation. Unlike GAPDH or AceS, acetylation appears to
influence PEPCK1 protein stability [15]. The wild type PEPCK protein is destabilized by
high glucose because gluconeogenesis is not needed under conditions of glucose sufficiency.
Importantly, substitution of three putative acetylation sites to alanine converts PEPCK to be
a stable protein even under high glucose conditions. Conversely, substitution of the
acetylated lysine residues by glutamine, which might mimic the effect of acetylation,
destabilizes PEPCK. Consistent with a role for acetylation in regulating PEPCK stability,
inhibition of deacetylase activity by TSA and nicotinamide destabilizes PEPCK even in
glucose-free medium. Collectively, these data establish a critical role of acetylation in
controlling PEPCK stability in response to extracellular glucose levels.
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The TCA cycle, coupled with oxidative phosphorylation, is the major pathway for aerobic
energy production. All eight enzymes in the TCA cycle are acetylated in human liver (Fig.
1B) [10,11,15]. In depth analyses of malate dehydrogenase (MDH), which utilizes NAD+ as
a co-factor to catalyze the reversible oxidation of malate to oxaloacetate, show that as many
as four lysine residues in MDH are acetylated. Several lines of evidence indicate that
acetylation activates MDH [15]. First, acetylation of MDH is stimulated by increasing
glucose concentrations in the culture medium. One might expect that high glucose would
promote cell metabolism and thus increase TCA cycle activity. Second, treatment of cells
with the deacetylase inhibitors TSA and nicotinamide increases MDH activity; this increase
is observed only for wild type MDH but not a mutant MDH in which the four acetylated
lysine residues are replaced by arginine. Third, in vitro deacetylation of MDH by purified
bacterial CobB deacetylase reduces MDH activity. Furthermore, increasing the
concentration of glucose stimulates the activity of wild type MDH, but not the acetylation
site mutant. These results indicate that MDH activity is activated by acetylation and that this
regulation is involved in the cellular response to glucose.
Acetylation appears to inhibit the activity of another TCA enzyme, succinate dehydrogenase
flavoprotein subunit (SDHA), the catalytic subunit of the four-subunit complex that oxidizes
succinate to fumarate [48]. SDHA acetylation is elevated, whereas its activity is lower, in
Sirt3 knockout mice, thereby identifying SIRT3 as a SDHA deacetylase and ascribing a role
for SIRT3 in SDHA activation. Acetylation of isocitrate dehydrogenase 2 (IDH2), which,
although it does not directly participate in the TCA cycle, catalyzes NADP+-dependent
oxidative decarboxylation of isocitrate to α-ketoglutarate in mitochondria, also appears to
inhibit its enzymatic activity. SIRT3-mediated deacetylation of purified IDH2 results in
increased IDH2 enzymatic activity, supporting the idea that acetylation inhibits IDH2. The
fact that acetylation has different effects on the activity of three TCA cycle enzymes,
stimulating MDH and inhibiting both SDH and IDH2, indicates the complex nature of this
regulation, including the specificity between modifying enzymes, acetyltransferases,
deacetylases, and substrates and distinct effects of acetylation on the enzymatic activity.
Lipid metabolism
A role for acetylation in lipid metabolism can be inferred by the acetylation-induced
inhibition of AceS [42,43]. Acetyl-CoA produced by AceS1 can be directly used for fatty
acid synthesis in the cytoplasm. More recent findings show that acetylation can directly
regulate enzymes involved in fatty acid oxidation. The bifunctional enzyme enoyl CoA
hydrotase/3-hydroxylacyl CoA dehydrogenase (EHHADH) catalyzes two sequential steps
during fatty acid β oxidation, hydration and oxidation (Fig. 1D). Acetylation modifies as
many as four different lysine residues in EHHADH and increases its enzymatic activity
[11,12,15]. Both the acetylation level and enzymatic activity of EHHADH are stimulated by
the addition of fatty acids to the culture medium. Quantitative MS analyses demonstrate that
a significant fraction of EHHADH in transfected cells can be acetylated. As much as half of
ectopically expressed EHHADH is acetylated at Lys346, and treatment of cells with TSA
and nicotinamide increases the fraction of Lsy346-acetylated EHHADH to as high as 78%.
These results point to the physiological importance of acetylation in regulating EHHADH
activity in response to metabolite fuel availability.
Deletion of the mitochondrial Sirt3 gene in mouse causes a global alteration of
mitochondrial protein acetylation, indicating that SIRT3 is a major deacetylase in the
mitochondrion [37]. The Sirt3 deficient liver shows decreased fatty acid oxidation with a
concomitant accumulation of fatty acid oxidation intermediates and triglycerides under
fasting conditions. These phenotypes are likely caused by a defect in the regulation of one or
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several enzymes involved in fatty acid metabolism [39]. Indeed, long-chain acyl CoA
dehydrogenase (LCAD) is hyperacetylated on lysine 42 in Sirt3 knockout cells, and in vitro
deacetylation of recombinant LCAD by SIRT3 increases its activity. These observations
demonstrate the importance of acetylation in negatively regulating LCAD activity through
the acetylation of a specific lysine residue. The physiological role of LCAD acetylation is
further supported by the fact that Sirt3 knockout mice have a reduced ATP level and cold
intolerance [38], findings that are consistent with a defect in fatty acid oxidation. Together,
these studies demonstrate an important role of acetylation in regulating mitochondrial fatty
acid oxidation and identify SIRT3 as a key deacetylase in this mode of regulation.
Amino acid metabolism
In addition to serving as building blocks for protein synthesis, amino acids can also be used
for energy production and other biosynthetic purposes. Many cancer cells require elevated
levels of glutamine [49]. Glutamate dehydrogenase (GDH), which catalyzes the reversible
reaction of converting glutamate and NAD+ to α-ketoglutarate, NADH, and ammonium, is
required for both glutamine utilization and glutamate synthesis. Indeed, inhibition of GDH
activity has been reported to sensitize glioblastoma cells to glucose deprivation [50]. In
liver, GDH is acetylated at as many as 11 lysine residues [10,11,15], and its acetylation also
increases during mouse CR [50]. Moreover, gain of function mutations in GDH causes
congenital hyperinsulinism in infants, a condition characterized by hypoglycemia and
hyperammonemia [51].
Two SIRTs, SIRT3 and SIRT4, physically bind and regulate GDH enzyme activity,
providing the first example where an individual metabolic enzyme is regulated by more than
one SIRT and thus responds to multiple nutrient conditions. In vitro deacetylation of GDH
by SIRT3 activates the enzyme [52], indicating that acetylation has an inhibitory role on
GDH. Further support for a role of SIRT3 in regulating GDH acetylation is generated by
analyzing Sirt3 knockout mice [37]. MS analysis identified GDH as a prominent acetylated
protein in the Sirt3 knockout liver. Moreover, GDH immunoprecipitated from Sirt3
knockout, but not the wild type, liver is highly acetylated. Similarly, the anti-acetyllysine
antibody can precipitate GDH from the Sirt3 knockout, but not the wild type, liver tissues.
These data strongly support that GDH is acetylated in liver and that SIRT3 is a major GDH
deacetylase.
SIRT4 is localized in mitochondria; however, no NAD+-dependent deacetylase activity of
SIRT4 has been demonstrated [4]. Instead, SIRT4 has NAD+-dependent ADP ribosylase
activity, which is also sensitive to inhibition by nicotinamide [40]. SIRT4 can physically
interact with GDH and ADP-ribosylate GDH in vitro. Importantly, ADP-ribosylation
appears to inhibit GDH activity as seen by the significant decrease of GDH specific activity
in Sirt4 deficient cells. Indeed, GDH ADP-ribosylation is altered in Sirt4 knockout cells.
These results establish a complex regulation of GDH by two different SIRTs: whereas one,
SIRT3, catalyzes deacetylation and activates GDH, the other, SIRT4, ADP-ribosylates and
inhibits GDH.
Urea cycle and nitrogen metabolism
The urea cycle is essential for ammonium detoxification, and mutations within genes
encoding urea cycle enzymes are common contributing factors to hyperammonemia,
especially during infancy [53]. All eight enzymes in the urea cycle and nitrogen metabolism
have been identified as being acetylated ([10-12,15], Fig. 1E), and the effects of acetylation
on three enzymes, CPS1, ornithine carbamoyltransferase (OTC), and argininosuccinate lyase
(ASL), have been experimentally tested [15,35,54]. CPS1 is the first enzyme of the urea
cycle, and as many as 12 lysine residues might be acetylated [10,15]. Affinity purification
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followed by MS analysis has identified CPS1 as a SIRT5 interacting protein; this interaction
was confirmed biochemically [35]. CPS1 activity is lower in the Sirt5 knockout liver, and in
vitro deacetylation by SIRT5 increases CPS1 activity. Interestingly, CPS1 activity in
primary hepatocytes is increased by starvation in a SIRT5-dependent manner; this
starvation-induced CPS1 activation is blunted in Sirt5 deficient hepatocytes. Furthermore,
starvation or a high protein diet increases CPS1 activity in liver of wild type, but not Sirt5
knockout mice. Under starvation conditions, animals must degrade proteins to generate
amino acids as nutrients for survival. Therefore, an elevated urea cycle is expected in
animals undergoing starvation. Similarly, animals on a high protein diet should have an
elevated urea cycle because the large quantity of amino acids generated will be used for
catabolism, thus demanding high CPS1 activity. Therefore, the regulation of CPS1 by
acetylation provides another excellent example for how acetylation can modulate
metabolism under physiological conditions in response to nutrient availability.
Further illustrating the role of acetylation in the regulation of the urea cycle is the finding
that acetylation inhibits the enzymatic activity of both OTC and ASL. OTC acts
immediately after CPS1 in the urea cycle. OTC mutations are a relatively common genetic
disorder in human and its deficiency causes symptoms ranging from newborn fatal to central
nervous system dysfunctions. Three different acetylated lysine residues have been identified
[10,15]. Acetylation of lysine 88 inactivates OTC enzymatic activity by decreasing the
affinity for its substrate, carbamoyl phosphate [54]. Notably, lysine 88 substitutions have
been found in human patients with urea cycle defects. Similar to the observations made for
CPS1, acetylation of lysine 88 is regulated by glucose availability. High glucose increases
OTC acetylation and at the same time decreases OTC1 activity, consistent with an inhibitory
role of acetylation in regulating OTC activity. Surprisingly, OTC acetylation is increased by
the addition of amino acids in the culture medium. The physiological significance of amino
acid-induced OTC acetylation is unclear; indeed, one might expect OTC activation under
amino acid-rich conditions.
Activity of ASL in the urea cycle is also regulated by acetylation [15]. Mutations in ASL
cause aciduria, the second most common neonatal disorder associated with malfunction of
the urea cycle [53]. Acetylation of lysine 288 inhibits ASL activity: high glucose inhibits
ASL activity by stimulating acetylation, whereas high concentrations of amino acids activate
the enzyme by inhibiting ASL acetylation. The urea cycle is coupled to amino acid
metabolism by detoxification of ammonium, and to the TCA cycle because fumarate
produced by ASL can be fed into the TCA cycle. A dual regulation of ASL by glucose and
amino acids might provide a possible mechanism of pathway coordination. For example,
glucose sufficiency would inhibit the utilization of amino acids for energy production. By
contrast, under glucose starvation, cells might hydrolyze non-essential proteins/organelles
(e.g. by autophagy) to produce amino acids for survival. Increased amino acid catabolism
for energy production would demand higher urea cycle activity to remove toxic ammonium.
Therefore, cells might utilize acetylation as a mechanism to coordinate multiple metabolic
pathways as a way to adapt to alterations in the environment.
Acetylation-mediated metabolic regulation is highly conserved during
evolution
Given the tremendous difference in their nutrient supply and divergence in the regulation of
many other cellular activities such as growth and proliferation, it is remarkable that
acetylation-mediated regulation of metabolic enzymes is highly conserved from prokaryotes
to eukaryotes, both in its extensiveness and mechanistic details. Two acetylation proteomic
studies have been conducted with E. coli and Salmonella [13] [14]. Both reports showed that
acetylation is highly prevalent in metabolic enzymes. For example, among the 91 acetylated
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proteins identified in E. coli, more than 50% are metabolic enzymes; by contrast, only two
transcription factors were found to be acetylated [13]. This would indicate that more than
half of the acetylated proteins are directly involved in metabolism. Although a systematic
proteomic acetylation study has not been performed for model eukaryotic organisms such as
yeast, C. elegans, and Drosophila, one might anticipate that metabolic enzymes in these
organisms are acetylated at a high frequency. Notably, many of the same enzymes are
acetylated in both bacteria and human. As exemplified by AceS, inactivation by acetylation
is a common regulatory mechanism in both Salmonella and mammals [41-43]. Moreover,
analogous lysine residues that are critical for catalytic activity are acetylated across species,
and the NAD+-dependent SIRT family deacetylases are responsible for AceS activation.
Hence, acetylation appears to be an ancient mechanism for regulating metabolism, and this
post-translational modification seems to be widely used in regulating many, if not most,
metabolic enzymes, thus supporting a fundamental role of acetylation in metabolic
regulation.
Concluding remarks
In addition to having a major role in regulating gene expression[1-3], recent studies have
revealed that acetylation plays a key role in coordinating overall cellular metabolism[10-15].
The extent to which acetylation regulates metabolism is comparable to well-established
post-translational modifications such as phosphorylation in the regulation of cell signaling or
ubiquitylation in the control of the cell cycle. Similar to regulation by phosphorylation,
acetylation appears to have divergent effects on substrates, including inhibition, activation,
and regulation of protein stability. These exciting discoveries reveal a new paradigm in
metabolic regulation and also raise a number of outstanding questions.
Why are so many enzymes in a given pathway acetylated?
Most metabolic pathways are not linear; rather, they form a network with many branches
from each pathway sharing common intermediates. Therefore, acetylation of multiple
enzymes might provide a mechanism of coordinating different pathways. For example,
nearly all enzymes involved in glycogen metabolism are acetylated16 (Fig. 1C). Glycogen
synthesis and glycogen hydrolysis must be coordinated to maintain certain levels of glucose
concentration and glycogen storage. Acetylation of these enzymes in glycogen synthesis and
hydrolysis could provide a means for such coordination. We propose that acetylation not
only regulates the rate of individual pathways but also has a critical role in coordinating the
entire metabolic network.
Does the concentration of Acetyl-CoA and NAD+ globally influence the acetylation level of
metabolic enzymes?
Acetyl-CoA is a key intermediate metabolite produced and consumed by many metabolic
reactions; as such, its cellular concentration is linked to many metabolic pathways. Thus,
any alterations in its concentration might modify and regulate metabolic pathways in
response to both extracellular and intracellular metabolic status. Similarly, NAD+ is used in
most reactions catalyzed by dehydrogenase and its reduced form, NADH, is the major
source for energy production by oxidative phosphorylation. Therefore, SIRT-dependent
deacetylation might couple cellular metabolic status with intracellular concentrations of a
key metabolite, NAD+. One example supporting this notion comes from a study that nuclear
histone acetylation in mammalian cells is dependent on ATP-citrate lyase (ACL), the
enzyme that converts glucose-derived citrate into acetyl-CoA [55].
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How do a limited number of acetyltransferases and deacetylases control the acetylation of
so many metabolic enzymes?
Thus far, fewer than 30 protein acetyltransferases and 18 deacetylases have been identified
in the human genome. Considering that only three SIRTs and one HDAC (HDAC7) are
known to be localized in the mitochondrion, the numbers of enzymes involved in the
deacetylation of mitochondrial metabolic enzymes are very small in comparison to the large
numbers of metabolic enzymes that are acetylated. The question becomes even more urgent
when considering that as many as 2,200 proteins undergo acetylation. By comparison, more
than 500 kinases and nearly 150 phosphatases provide a high degree of substrate specificity
for phosphorylation. Similarly, as many as 1,000 E3 ubiquitin ligases and 79
deubiquitylating enzymes (DUBs) are expressed or assembled in mammalian cells. Is there a
class of yet-to-be-defined factors or mechanism for recruiting specific substrates to an
acetyltransferase and/or deacetylase, as is the case for recruiting specific substrates by E3
ubiquitin ligases? Could some metabolic enzymes be acetylated in the cytoplasm before
import into mitochondria? Could the high levels of acetyl-CoA directly cause lysine
acetylation, which would explain the lack of identification of cytoplasmic and mitochondrial
protein acetyltransferases in metabolic regulation?
Understanding these and many other questions emerging from recent studies of acetylation
in metabolism will advance our knowledge of metabolic regulation, including an
understanding of ways in which metabolic pathways are altered in human disease. In
addition to such diseases as cardiovascular diseases, diabetes, obesity and inherited newborn
metabolic disorders that have long been linked to dysregulated metabolic enzymes, altered
metabolism in tumor cells, that was actually recognized more than 80 years ago by Otto
Warburg, is being rediscovered as a key contributor to cancer development. The large
number and wide variety of metabolic enzymes, including those from all six main families
(oxidases or dehydrogenases, hydrolases, ligases, lyases, isomerases and transferases), offer
many potential targets for therapeutic intervention in these metabolic diseases.
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a dietary regimen that restricts caloric intake by experimental
organisms, in contrast to control organisms that are provided with
unrestricted food. CR has a long history of research in a wide range
of model organisms, including yeast, C. elegans, Drosophila, and
mammals, and consistently has been found to increase both the
median and maximum lifespan. Although the mechanism
underlying extended life span by CR remains incompletely
understood, altered metabolic activity appears to be a major





a group of enzymes that transfer an acetyl group from acetyl-CoA
to form ε-N-acetyl lysine. Although first discovered as enzymes
that acetylate conserved lysine residues on histones and thus so
named, recent recommendations suggest renaming them as lysine-
acetyltransferases (KATs) to reflect their broad function in
regulating a great number of non-histone proteins [56], including
many metabolic enzymes discussed herein.
Intermediary
metabolism
often referred to simply as metabolism, includes all steps between
extracellular foodstuffs or nutrients and cellular components. These
steps are catalyzed by enzymes within the cell and provide energy,
reducing power and building blocks for maintaining cellular
homeostasis or supporting cell growth.
Protein lysine
deacetylases
also known as histone deacetylases, HDACs. These comprise a
group of hydrolases that remove acetyl groups from the ε-amine of
lysine side chains. Although histone proteins were the first
identified HDAC substrates, it is now clear that the HDAC
substrate spectrum is much broader. Although HDACs have been
referred to in some literature as KDACs to more precisely describe
their function toward numerous non-histone proteins, recent
recommendations suggest against the renaming to avoid confusion
owing to the long history of its reference in the literature [56].
Sirtuins (SIRTs) SIRT proteins were named after its founding member Sirtuin,
which was derived from silent information regulator two (Sir2)
proteins, originally identified and then isolated in a screen for
mutations that suppresses the mating and sporulation defects in
budding yeast[57,58]. They are categorized as class III protein
lysine deacetylases that possess NAD+-dependent deacetylase
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[59-61] except for SIRT4, which does not exhibit deacetylase
activity and instead possesses NAD+-dependent ADP ribosylase
activity [40,62], and SIRT6 which exhibits both NAD+-dependent
deacetylase and ADP ribosylase activities [63]. SIRTs are
structurally distinct from other classes of HDACs; they represent
an evolutionarily conserved multigene family, including two genes
in yeast, C.elegans and Arabidopsis thaliana, five in Drosophila,
sea urchin and zebrafish, seven in Xenopus laevis, chicken and
mammals [64]. The rate of SIRT-mediated ADP-ribosylation,
however, seems to be very low [65], which, when considered
together with the fact that most eukaryotes express poly-ADP-
ribose polymerases (PARPs) that can catalyze ribosylation more
efficiently, raises the question of its physiological relevance and
whether it represents a side reaction of deacetylation.
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Figure 1. Acetylation regulation of metabolic enzymes
Most intermediate metabolic enzymes are acetylated. The five major pathways that include
enzymes whose regulation by acetylation has been characterized—gluconeogenesis (a),
glycolysis (b), glycogen metabolism (C), fatty acid metabolism (d) and the urea cycle and
nitrogen metabolism (e)--are illustrated. Substrates and products are colored in black.
Metabolic enzymes are colored in red if their acetylations have been identified or blue if not.
The red arrows, facing up or down, next to the enzymes indicate a stimulatory or inhibitory
effect, respectively, on the enzyme activity by acetylation as determined by in vitro
biochemical experiments
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